Nephros (NEPH) Net Income Growth (3y) (2013 - 2026)
Nephros (NEPH) Net Income Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 125.07 Bn | 119.86 Bn | 1.96 Bn | 24.56% |
| 2 | Becton Dickinson | 44.44 Bn | 43.62 Bn | 2.15 Bn | - |
| 3 | Alcon | 33.12 Bn | 31.46 Bn | 1.53 Bn | 2.79% |
| 4 | Medline | 32.64 Bn | 30.40 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.01 Bn | 27.35 Bn | 890.98 Mn | 19.70% |
| 6 | West Pharmaceutical Services | 23.58 Bn | 23.14 Bn | 329.20 Mn | -0.49% |
| 7 | Solventum | 13.92 Bn | 13.36 Bn | 1.10 Bn | -64.60% |
| 8 | Cooper Companies | 13.88 Bn | 13.74 Bn | 735.40 Mn | -58.17% |
| 9 | Align Technology | 12.22 Bn | 11.16 Bn | 736.59 Mn | 8.69% |
| 10 | Nephros | 36.66 Mn | 32.64 Mn | 2.99 Mn | 27.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.30% |
| Dec 31, 2025 | 35.37% |
| Sep 30, 2025 | 38.59% |
| Jun 30, 2025 | 37.64% |
| Mar 31, 2025 | -30.34% |
| Dec 31, 2024 | 46.56% |
| Sep 30, 2024 | 35.87% |
| Jun 30, 2024 | 36.97% |
| Mar 31, 2024 | 41.29% |
| Dec 31, 2023 | 15.49% |
| Sep 30, 2023 | -2.44% |
| Jun 30, 2023 | 28.67% |
| Mar 31, 2023 | 26.82% |
| Dec 31, 2022 | 23.66% |
| Sep 30, 2022 | 20.89% |
| Jun 30, 2022 | 31.27% |
| Mar 31, 2022 | 34.91% |
| Dec 31, 2021 | 21.53% |
| Sep 30, 2021 | 12.75% |
| Jun 30, 2021 | -13.56% |